BioSpace News Archive

HUTCHMED Limited announces that, further to its announcement in March 2021 and following receipt of regulatory approval, it has completed the sale of its entire indirect interest in Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company Limited, a non-core and non-consolidated over-the-counter drug joint venture business, to GL Mountrose Investment Two Limited, a company controlled and managed by GL Capital Group.

Innovent Biologics, Inc.released the preliminary results of the Phase Ia study of IBI315 (first-in-class anti-Her2/PD-1 bispecific antibody) in an oral presentation at the 2021 Annual Meeting of Chinese Society of Clinical Oncology (CSCO).

Renovacor to Present at the Chardan Virtual 5 th Annual Genetic Medicines Conference

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies (tumor-infiltrating lymphocyte, TIL, and peripheral-blood lymphocyte, PBL), is celebrating the official opening of the Iovance Cell Therapy Center (iCTC).

PharmaTher Holdings Ltd. is pleased to announce that it has closed its previously announced private placement with institutional investors of its common shares

LumiraDx’s common shares will commence trading on September 29, 2021 on Nasdaq under the ticker symbol “LMDX”

Fortress Biotech, Inc. announced that Lindsay A. Rosenwald, M.D., Chairman, President and Chief Executive Officer, will participate in the Benzinga Healthcare Small Cap Conference, scheduled to take place from September 29-30, 2021.

Selux Diagnostics, Inc., which is leading a new era in personalized diagnostics to combat superbug infections and fight antibiotic resistance, announced that its Next Generation ‘Phenotyping’ platform has received Breakthrough Device Designation from the U.S. Food and Drug Administration for positive blood culture and sterile body fluid samples.

Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying and developing therapeutics that address cardio-pulmonary diseases with high unmet medical need, today announced that management will present a company overview at the virtual Benziga Healthcare Small Cap Conference being held from September 29-30, 2021.

NEOGEN Corporation (NASDAQ: NEOG) announced today that they have partnered with Hendrix Genetics, a multi-species animal breeding, genetics, and technology company.